LIFEVANTAGE CORP Public Float
LIFEVANTAGE CORP (LFVN) had Public Float of $63.70 million as of 2025-12-31, per its 10-K filed 2026-08-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-08-27
- 2025-12-31: Entity Public Float $63.70M.
- 2024-12-31: Entity Public Float $220.00M.
- 2023-12-31: Entity Public Float $68.10M.
- 2022-12-31: Entity Public Float $44.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-12-31 | $63.70M 10-K · filed 2026-08-27 |
| 2024-12-31 | $220.00M 10-K · filed 2025-09-04 |
| 2023-12-31 | $68.10M 10-K · filed 2024-08-28 |
| 2022-12-31 | $44.20M 10-K · filed 2023-08-28 |
| 2021-12-31 | $81.20M 10-K · filed 2022-08-23 |
| 2020-12-31 | $131.90M 10-K · filed 2021-08-19 |
| 2019-12-31 | $223.10M 10-K · filed 2020-08-18 |
| 2018-12-31 | $188.20M 10-K · filed 2019-08-14 |
| 2017-12-31 | $67.60M 10-K · filed 2018-08-15 |
| 2016-12-31 | $114.50M 10-K · filed 2017-09-07 |
| 2015-12-31 | $133.20M 10-K · filed 2016-12-12 |
| 2014-12-31 | $128.50M 10-K · filed 2015-09-01 |
| 2013-12-31 | $171.40M 10-K · filed 2014-09-10 |
| 2012-12-31 | $243.70M 10-K · filed 2013-09-12 |
| 2011-12-31 | $143.00M 10-K · filed 2012-09-10 |
| 2010-12-31 | $68.47M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |